| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |